Protalix Biotherapeutics (PLX) Stock Price, Quote & News

Company Profile

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for...

Industry: Biotechnology

Sector: Healthcare

Phone: 201 696 9345

Website: www.protalix.com

Address:

2 University Plaza, Suite 100, Hackensack, United States

Plumberhouston Oct. 25 at 8:21 PM

$PLX Nice come back this week. I picked up another 20k at 1.90 on the crazy drop we had. Can’t wait until they start dosing 115.

0 · Reply

MoneyGroupLLC Oct. 25 at 7:21 PM

Enter: $PLX Calls Strike Price: $2 Expiry Date: NOV 21 2025 Buy in Price: $0.19 - $0.20 Sell Price: $0.31 Profit : +63% (Turn every $1 into $1.63) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/

0 · Reply

BryGuy29 Oct. 25 at 6:28 PM

$PLX interesting video https://youtu.be/o9uQee6cJ3k?si=iR2TOp_QoJcjwDGQ

1 · Reply

jeremy0916 Oct. 25 at 1:50 PM

$PLX The recovery from the knife is wild. Is something happening this quarter we don’t know but someone else does? I assume about 20 mil in revs and kickoff of gout but that was about it. Maybe a $10 mil sales milestone? Chiesi if you want PLX cheap this is the year amd quarter to do so ❤️. 🤣

3 · Reply

PLX_BULLS Oct. 25 at 12:49 AM

$PLX Another example of why we would be better off on the Nasdaq, ie, ARDX 241m shares outstanding, EBITDA of -36m WITH 234m DEBT and trades at 5$! Freaking insane! PLX will have a positive EBITDA of 36m eoy 2025, 80m shares, O debt???

0 · Reply

jcon777 Oct. 24 at 10:24 PM

$PLX anyone have any thoughts on why PLX mgmt might just simply write a poison pill contract to avoid a cheap buyout?

1 · Reply

charleston_invest Oct. 24 at 8:50 PM

$PLX I can understand the BO whispering startng again when it is becoming apparent that Sanofi is beginning the decent to lose more in sales of Fabrazyme than it will cost them to purchase Protalix ( at the current rock bottom valuation- even at some multiple) not too mention of course all of the other perks which come with purchasing Protalix technology.

2 · Reply

smartmoney43 Oct. 24 at 8:33 PM

$PLX was there a dip a week ago? 😂

1 · Reply

zoomlik Oct. 24 at 7:55 PM

$PLX It is a buyout in play

0 · Reply

charleston_invest Oct. 24 at 7:47 PM

$PLX Can only imagine where we would be if last Friday had gone different

1 · Reply

Why Is Protalix BioTherapeutics Stock Falling On Friday?

Oct 17, 2025, 6:58 AM EDT - 8 days ago

Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio® (pegunigalsidase alfa) in the EU

Sep 11, 2025, 10:55 AM EDT - 6 weeks ago

Protalix BioTherapeutics to Present at Investor Summit Virtual

Sep 2, 2025, 6:50 AM EDT - 7 weeks ago

Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 25, 2025, 6:57 AM EDT - 2 months ago

Protalix: Speculative Buy On Promising Plant-Cell Platform And Elfabrio Ramp

Aug 14, 2025, 12:47 PM EDT - 2 months ago

Protalix BioTherapeutics, Inc. (PLX) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 6:50 AM EDT - 2 months ago

Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results

Aug 7, 2025, 12:53 PM EDT - 2 months ago

Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025

Jul 21, 2025, 6:50 AM EDT - 3 months ago

Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer

Jun 30, 2025, 6:50 AM EDT - 4 months ago

Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®

May 14, 2025, 6:50 AM EDT - 5 months ago

Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

May 9, 2025, 4:12 PM EDT - 6 months ago

Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript

May 9, 2025, 6:50 AM EDT - 6 months ago

Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results

May 5, 2025, 6:50 AM EDT - 6 months ago

Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025

Apr 10, 2025, 9:54 AM EDT - 7 months ago

Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline

Mar 24, 2025, 6:50 AM EDT - 7 months ago

Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025

Mar 17, 2025, 11:56 AM EDT - 7 months ago

Protalix BioTherapeutics Says With Debt Fully Repaid, It's Well-Positioned To Execute Strategy Through 2025 And Beyond

Mar 17, 2025, 10:22 AM EDT - 7 months ago

Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 6:50 AM EDT - 7 months ago

Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results

Mar 10, 2025, 6:50 AM EDT - 8 months ago

Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025

Feb 4, 2025, 6:50 AM EST - 9 months ago

Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference

Dec 23, 2024, 6:50 AM EST - 10 months ago

Protalix BioTherapeutics Issues 2025 Letter to Stockholders

Dec 9, 2024, 6:30 AM EST - 11 months ago

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa

Nov 14, 2024, 11:23 AM EST - 1 year ago

Protalix BioTherapeutics, Inc. (PLX) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 6:50 AM EST - 1 year ago

Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results

Nov 7, 2024, 6:50 AM EST - 1 year ago

Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024

Oct 25, 2024, 7:18 AM EDT - 1 year ago

Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024

Sep 17, 2024, 8:00 AM EDT - 1 year ago

Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm

Sep 16, 2024, 8:35 AM EDT - 1 year ago

Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024

Sep 4, 2024, 6:50 AM EDT - 1 year ago

Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 3, 2024, 6:50 AM EDT - 1 year ago

Protalix BioTherapeutics Announces Repayment of Outstanding Senior Secured Convertible Promissory Notes

Aug 14, 2024, 10:32 AM EDT - 1 year ago

Protalix BioTherapeutics, Inc. (PLX) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 6:50 AM EDT - 1 year ago

Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results

Aug 7, 2024, 6:50 AM EDT - 1 year ago

Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024

Jun 13, 2024, 6:50 AM EDT - 1 year ago

Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout

May 29, 2024, 8:38 AM EDT - 1 year ago

Protalix BioTherapeutics to Present at the 2024 BIO International Convention

May 10, 2024, 11:13 AM EDT - 1 year ago

Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript

May 10, 2024, 6:50 AM EDT - 1 year ago

Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results

May 3, 2024, 6:50 AM EDT - 1 year ago

Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024

Mar 14, 2024, 1:02 PM EDT - 1 year ago

Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 6:50 AM EDT - 1 year ago

Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results

Mar 7, 2024, 6:50 AM EST - 1 year ago

Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024

Feb 23, 2024, 6:50 AM EST - 1 year ago

Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference

Dec 26, 2023, 6:50 AM EST - 1 year ago

Protalix BioTherapeutics Issues 2024 Letter to Stockholders

Nov 6, 2023, 11:57 AM EST - 2 years ago

Protalix Biotherapeutics, Inc. (PLX) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 6:50 AM EST - 2 years ago

Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results

Oct 30, 2023, 6:50 AM EDT - 2 years ago

Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023

Oct 9, 2023, 8:53 AM EDT - 2 years ago

These Israeli pharmaceutical stocks are down in the wake of Hamas attack

CGEN KMDA TARO TEVA

Plumberhouston Oct. 25 at 8:21 PM

$PLX Nice come back this week. I picked up another 20k at 1.90 on the crazy drop we had. Can’t wait until they start dosing 115.

0 · Reply

MoneyGroupLLC Oct. 25 at 7:21 PM

0 · Reply

BryGuy29 Oct. 25 at 6:28 PM

$PLX interesting video https://youtu.be/o9uQee6cJ3k?si=iR2TOp_QoJcjwDGQ

1 · Reply

jeremy0916 Oct. 25 at 1:50 PM

3 · Reply

PLX_BULLS Oct. 25 at 12:49 AM

0 · Reply

jcon777 Oct. 24 at 10:24 PM

$PLX anyone have any thoughts on why PLX mgmt might just simply write a poison pill contract to avoid a cheap buyout?

1 · Reply

charleston_invest Oct. 24 at 8:50 PM

2 · Reply

smartmoney43 Oct. 24 at 8:33 PM

$PLX was there a dip a week ago? 😂

1 · Reply

zoomlik Oct. 24 at 7:55 PM

$PLX It is a buyout in play

0 · Reply

charleston_invest Oct. 24 at 7:47 PM

$PLX Can only imagine where we would be if last Friday had gone different

1 · Reply

PLX_BULLS Oct. 24 at 7:15 PM

$PLX we got a arse hole selling big at 2.41.

2 · Reply

PLX_BULLS Oct. 24 at 6:57 PM

$PLX possible 2.45 close!

1 · Reply

Manonfire8 Oct. 24 at 6:52 PM

$PLX how do we all feel about 3Q earnings? I actually feel confident it'll follow the same pattern as last year where we crushed year end. Would love to see +5

0 · Reply

PLX_BULLS Oct. 24 at 6:33 PM

$PLX Hold your shares and let this MF pop!

1 · Reply

PLX_BULLS Oct. 24 at 6:30 PM

$PLX @Supreme10 best news today was the numbers Supreme provided today from Fabrazyme sales. Awesome we took 3.7% from them in the 2Q and 4.3 in the 3Q :)

1 · Reply

PLX_BULLS Oct. 24 at 6:09 PM

$PLX another buyer shows up and we’ll see 2.40 today. Nice bid at 2.35!

0 · Reply

MoneyGroupLLC Oct. 24 at 5:24 PM

Enter: $PLX NOV 21 2025 $2 CALLS Buy in Price: $0.15 - $0.20 Take Profit: $0.19 Stop Bleeding: $0.13 ROI Potential: 26% https://moneygroup.us/

0 · Reply

WhatsUpWhatsNot Oct. 24 at 5:21 PM

$PLX once again the future numbers win again..time, after time, after time…but do your homework.

0 · Reply

PLX_BULLS Oct. 24 at 5:07 PM

$PLX nice :)

0 · Reply

CliffordCapital Oct. 24 at 4:49 PM

$PLX can we get a closing Rallye like we had the last couple of days? :)

0 · Reply

Artfldgr Oct. 24 at 4:29 PM

$PLX Key Points The consumer price index showed a 0.3% increase on the month, putting the annual inflation rate at 3%, both lower than expected. Excluding food and energy, core CPI showed a 0.2% monthly gain and an annual rate also at 3%, also less than forecasts. The BLS released the data specifically because the Social Security Administration uses it as a benchmark for cost-of living adjustments in benefit checks.

0 · Reply

Artfldgr Oct. 24 at 1:13 PM

$PLX Happy friday all!

1 · Reply

Market Cap	184.18M
Revenue (ttm)	53.40M
Net Income (ttm)	2.93M
EPS (ttm)	N/A
PE Ratio	32.43
Forward PE	17.46
Profit Margin	5.49%
Debt to Equity Ratio	0.00

Volume	740,600
Avg Vol	870,492
Day's Range	N/A - N/A
Shares Out	79.73M
Stochastic %K	80%
Beta	-0.13
Analysts	Strong Sell
Price Target	$14.00